The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sopheon Announces Agreement to Acquire Alignent Software

11 Jun 2007 14:30

Sopheon, the international software and services company,announced today that it has signed a definitive agreement to acquireAlignent Software Inc. The cash-based transaction is expected to becompleted on or about June 18, 2007. £ Based in California, Alignent is one of only a few suppliersworldwide that specializes in the provision of advanced product andtechnology roadmapping software for complex global companies.Alignent's flagship offering, Vision Strategist, is generallyrecognized as the leading application of its kind. The software has aproven track record of helping large organizations improve strategicinnovation planning. Some of the foremost aerospace, defense andhigh-tech companies in the world, including Boeing, BAE Systems,Corning, Honeywell, Lockheed Martin, Motorola and NAVAIR have adoptedAlignent's offering as their product planning solution. £ Alignent's roadmapping software is an ideal complement toSopheon's existing product innovation process and portfolio managementsystem. Vision Strategist allows the user to visualize and predict howexternal market and technology trends will impact product plans overtime, enabling better decisions on future product direction. Aprincipal advantage of the software is that it improvescross-functional communication and collaboration throughout theplanning process. Sopheon's Accolade(R) software enhances theexecution of product plans by automating innovation processgovernance. Although the two applications will continue to be marketedseparately, together they will constitute industry's first end-to-endstrategic product planning software suite. £ The acquisition of Alignent will immediately expand Sopheon'sbusiness in two areas. First, for the company's nearly 100 existingclients in chemical and consumer packaged goods markets, it willextend Sopheon's solution to include strategic product planning.Secondly, Alignent's roster of industry-leading customers will giveSopheon instant credibility in a range of new markets, acceleratingits entry into aerospace, defense and high-tech. £ Sopheon estimates that the acquisition will advance its productplans for Accolade by a full two years. It will also result in asubstantial increase in the size of Sopheon's customer base. Initialfeedback indicates that Sopheon can expect to achieve significantorganic growth by selling its Accolade solution to existing Alignentclients challenged with improving innovation process governance.Sopheon expects to begin offering Accolade's product portfoliomanagement capabilities to Alignent customers this summer. £ "Our acquisition of Alignent represents significant strategicvalue to Sopheon," said Barry Mence, Sopheon's chairman. "It will helpus deepen our penetration in the chemicals and consumer goods marketswe currently target, while accelerating our expansion into new marketssuch as aerospace, defense and high-tech, which offer great upsidegrowth potential. We expect substantial near- and long-term revenuebenefits from the transaction, as well as enhanced earnings on anongoing basis. This is a very positive move for our company, for ourclients and for our shareholders." £ "Sopheon has already established strong market position as thepremier provider of software applications for governance of theinnovation process," said Dennis Clerke, chief executive officer ofAlignent. "The addition of Alignent's products, people and partnerswill enable Sopheon to deliver an unmatched set of strategic productplanning and execution solutions to business and R&D decision makers.This is an exciting development that will yield significant benefitsnot only to Alignent's customers, but to global manufacturers in allsectors of industry." £ Alignent reported revenues of $3 million and a $4.3 million netoperating loss for 2006. Completion of the transaction is contingentupon the receipt of consents from Alignent shareholders and thedelivery of ancillary agreements and formalities. Gross considerationfor the acquisition amounts to $5.5 million, including $4.75 millioninitially upon closing and an additional $750 thousand in potentialearn-out payments. Sopheon expects the Alignent business to make apositive EBITDA contribution from the first year following thepurchase. £ Accolade(R) is a registered trademark of Sopheon plc. £ All other trademarks and registered trademarks are the soleproperty of their respective owners. £ About Alignent Software £ Alignent software company supports the powerful process ofroadmapping. Alignent's solutions dynamically connect product andtechnology planning across the company, empowering organizations tovisualize, manage and communicate future directions within a singlesystem. Alignent focuses R&D efforts, fosters cross-functionalcollaboration and aligns people around a unified plan of record thatadapts in real-time to empower accurate, timely business decisions.The world's most sophisticated product and technology planners rely onAlignent, including BAE Systems, Corning, Honeywell, Lockheed Martin,Medtronic, Motorola, Philips, Textron, the U.S. Air Force and the U.S.Navy. For more information, please visit www.alignent.com. £ About Sopheon £ Sopheon (LSE:SPE) is an international provider of software andservices that help organizations improve the business impact ofproduct innovation. Sopheon's Accolade system automates and governsthe innovation process, enabling companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. Copyright Business Wire 2007
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.